Colossal Biosciences
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
2
Funding Rounds
$260.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Colossal Biosciences has raised a total of $260m in funding over 2 rounds.
Key Insights:
- Colossal Biosciences January 2024 Series C Funding Round: $200m
- Colossal Bioscience Series A round, September 2022: $60m
Colossal Biosciences January 2024 Series C Funding Round
$200m
Colossal Bioscience Series A round, September 2022
$60m
Industries
Colossal Biosciences is active in the following industries:
- Biotechnology
- Genomics
- Genome editing